These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10617295)

  • 41. Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics.
    Dellamary L; Smith DJ; Bloom A; Bot S; Guo GR; Deshmuk H; Costello M; Bot A
    J Control Release; 2004 Mar; 95(3):489-500. PubMed ID: 15023460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. History of aerosol therapy: liquid nebulization to MDIs to DPIs.
    Anderson PJ
    Respir Care; 2005 Sep; 50(9):1139-50. PubMed ID: 16122398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging aerosol drug delivery strategies: from bench to clinic.
    Rubin BK; Williams RW
    Adv Drug Deliv Rev; 2014 Aug; 75():141-8. PubMed ID: 24993613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments.
    Pritchard JN; Hatley RH; Denyer J; Hollen DV
    Ther Deliv; 2018 Feb; 9(2):121-136. PubMed ID: 29325508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlling the droplet size of formulations nebulized by vibrating-membrane technology.
    Beck-Broichsitter M; Knuedeler MC; Seeger W; Schmehl T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):524-9. PubMed ID: 24657823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013.
    Kamin W; Erdnüss F; Krämer I
    J Cyst Fibros; 2014 May; 13(3):243-50. PubMed ID: 24172851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical aerosol electrostatics: a field with much potential for development.
    Lip Kwok PC
    Ther Deliv; 2015 Feb; 6(2):105-7. PubMed ID: 25690079
    [No Abstract]   [Full Text] [Related]  

  • 49. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary formulations: what remains to be done?
    Weers JG; Bell J; Chan HK; Cipolla D; Dunbar C; Hickey AJ; Smith IJ
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S5-23. PubMed ID: 21133800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system.
    Votion D; Ghafir Y; Munsters K; Duvivier DH; Art T; Lekeux P
    Equine Vet J; 1997 Sep; 29(5):388-93. PubMed ID: 9306067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.
    Ruge CA; Kirch J; Lehr CM
    Lancet Respir Med; 2013 Jul; 1(5):402-13. PubMed ID: 24429205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting delivery of aerosols to different lung regions.
    Bennett WD; Brown JS; Zeman KL; Hu SC; Scheuch G; Sommerer K
    J Aerosol Med; 2002; 15(2):179-88. PubMed ID: 12184868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers.
    Goralski JL; Davis SD
    Respir Med; 2014 Aug; 108(8):1069-74. PubMed ID: 25012949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmaceutical considerations in aerosol drug delivery.
    Kuhn RJ
    Pharmacotherapy; 2002 Mar; 22(3 Pt 2):80S-85S. PubMed ID: 11898885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aerosol delivery devices.
    Crompton GK; Barnes PJ
    Chest; 2006 May; 129(5):1388-9; author reply 1389. PubMed ID: 16685035
    [No Abstract]   [Full Text] [Related]  

  • 57. Controlled delivery of inhaled therapeutic agents.
    Hickey AJ
    J Control Release; 2014 Sep; 190():182-8. PubMed ID: 24907604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drugs by inhalatory route: an overview and upcoming clinical perspectives.
    Melillo EM; Balzano G
    Monaldi Arch Chest Dis; 1996 Oct; 51(5):405-12. PubMed ID: 9009629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary delivery systems for polyphenols.
    Trotta V; Scalia S
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1043-1052. PubMed ID: 28276786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol.
    Gilbert BE; Knight C; Alvarez FG; Waldrep C; Rodarte JR; Knight V; Eschenbacher WL
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1789-93. PubMed ID: 9412556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.